Low Molecular Weight Hyaluronan Activates Cytosolic Phospholipase A2α and Eicosanoid Production in Monocytes and Macrophages

Milena Sokolowska; Michael Eberlein; Li-Yuan Chen; Asuncion Martinez-Anton; Yueqin Liu; Sara Alsaaty; Hai-Yan Qi; Carolea Logun; Maureen Horton; James H Shelhamer

doi:10.1074/jbc.M113.515106

Back

Low Molecular Weight Hyaluronan Activates Cytosolic Phospholipase A2α and Eicosanoid Production in Monocytes and Macrophages

Journal article

Open access

Peer reviewed

Low Molecular Weight Hyaluronan Activates Cytosolic Phospholipase A2α and Eicosanoid Production in Monocytes and Macrophages

Milena Sokolowska, Michael Eberlein, Li-Yuan Chen, Asuncion Martinez-Anton, Yueqin Liu, Sara Alsaaty, Hai-Yan Qi, Carolea Logun, Maureen Horton and James H Shelhamer

The Journal of biological chemistry, Vol.289(7), pp.4470-4488

02/14/2014

DOI: 10.1074/jbc.M113.515106

PMCID: PMC3924308

PMID: 24366870

Files and links (1)

url

https://doi.org/10.1074/jbc.M113.515106View

Published (Version of record) Open Access

Abstract

Hyaluronan (HA) is the major glycosaminoglycan in the extracellular matrix. During inflammation, there is an increased breakdown of HA, resulting in the accumulation of low molecular weight (LMW) HA and activation of monocytes and macrophages. Eicosanoids, derived from the cytosolic phospholipase A2 group IVA (cPLA2α) activation, are potent lipid mediators also attributed to acute and chronic inflammation. The aim of this study was to determine the effect of LMW HA on cPLA2α activation, arachidonic acid (AA) release, and subsequent eicosanoid production and to examine the receptors and downstream mechanisms involved in these processes in monocytes and differently polarized macrophages. LMW HA was a potent stimulant of AA release in a time- and dose-dependent manner, induced cPLA2α, ERK1/2, p38, and JNK phosphorylation, as well as activated COX2 expression and prostaglandin (PG) E2 production in primary human monocytes, murine RAW 264.7, and wild-type bone marrow-derived macrophages. Specific cPLA2α inhibitor blocked HA-induced AA release and PGE2 production in all of these cells. Using CD44, TLR4, TLR2, MYD88, RHAMM or STAB2 siRNA-transfected macrophages and monocytes, we found that AA release, cPLA2α, ERK1/2, p38, and JNK phosphorylation, COX2 expression, and PGE2 production were activated by LMW HA through a TLR4/MYD88 pathway. Likewise, PGE2 production and COX2 expression were blocked in Tlr4−/− and Myd88−/− mice, but not in Cd44−/− mice, after LMW HA stimulation. Moreover, we demonstrated that LMW HA activated the M1 macrophage phenotype with the unique cPLA2α/COX2high and COX1/ALOX15/ALOX5/LTA4Hlow gene and PGE2/PGD2/15-HETEhigh and LXA4low eicosanoid profile. These findings reveal a novel link between HA-mediated inflammation and lipid metabolism. Fragmented hyaluronan (a major extracellular matrix component) and eicosanoids (potent lipid mediators) are associated with chronic inflammatory diseases and cancer. Fragmented hyaluronan stimulates lipid mediator production in human monocytes and macrophages and influences macrophage differentiation toward a distinct activation pattern. These findings reveal a novel link between hyaluronan-mediated inflammation and lipid metabolism. This link may provide new targets for disease therapeutics.

Extracellular Matrix

Inflammation

Toll-like Receptors (TLR)

Hyaluronan

Macrophage Polarization

Monocytes

Prostaglandin

Eicosanoid

cPLA2

Cyclooxygenase (COX) Pathway

Details

Title: Subtitle: Low Molecular Weight Hyaluronan Activates Cytosolic Phospholipase A2α and Eicosanoid Production in Monocytes and Macrophages
Creators: Milena Sokolowska - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Michael Eberlein - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Li-Yuan Chen - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Asuncion Martinez-Anton - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Yueqin Liu - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Sara Alsaaty - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Hai-Yan Qi - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Carolea Logun - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Maureen Horton - Division of Pulmonary and Critical Care Medicine, The John Hopkins University, Baltimore, Maryland 21205
James H Shelhamer - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Resource Type: Journal article
Publication Details: The Journal of biological chemistry, Vol.289(7), pp.4470-4488
DOI: 10.1074/jbc.M113.515106
PMID: 24366870
PMCID: PMC3924308
NLM abbreviation: J Biol Chem
ISSN: 0021-9258
eISSN: 1083-351X
Publisher: Elsevier Inc
Language: English
Date published: 02/14/2014
Academic Unit: Pulmonary, Critical Care, and Occupational Medicine; Internal Medicine
Record Identifier: 9984094776002771

Metrics

19 Record Views

90 Times Cited - Web of Science